Outset Medical, Inc.
OMNasdaqCIK 1484612HealthcareFiscal year ends Dec 31
Reports and events: 101 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-2820:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-374323 |
| 2026-08-0621:15 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-338432 |
| 2026-08-0620:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-337953 |
| 2026-06-1720:05 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-274135 |
| 2026-06-0520:05 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-259527 |
| 2026-05-2920:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-248237 |
| 2026-05-0721:30 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-212481 |
| 2026-05-0720:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-211980 |
| 2026-04-2420:06 ET | DEF 14A | Proxy statementPeriod 2026-06-04 | 0001193125-26-177150 |
| 2026-02-1321:01 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-051278 |
| 2026-02-1121:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-046588 |
| 2026-01-2714:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-023428 |
| 2026-01-1213:31 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-009865 |
| 2025-11-1022:00 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-274504 |
| 2025-11-1021:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-274193 |
| 2025-08-0721:54 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-104300 |
| 2025-08-0620:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-104054 |
| 2025-06-0320:35 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-081009 |
| 2025-05-1413:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-070964 |
| 2025-05-0821:45 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-066003 |
| 2025-05-0720:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-065680 |
| 2025-04-1120:43 ET | DEF 14A | Proxy statementPeriod 2025-06-02 | 0000950170-25-053260 |
| 2025-03-2020:01 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-25-058953 |
| 2025-03-1812:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-056206 |
| 2025-03-1120:35 ET | 8-K | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-051981 |
| 2025-03-0621:05 ET | 8-K | 5.07 Shareholder vote results | 0000950170-25-034593 |
| 2025-02-2821:24 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-030045 |
| 2025-02-2621:10 ET | 8-K | 3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-036741 |
| 2025-02-1921:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-023167 |
| 2025-02-0421:58 ET | DEF 14A | Proxy statementPeriod 2025-03-05 | 0001140361-25-003034 |
| 2025-01-2422:17 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001140361-25-001915 |
| 2025-01-0821:37 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-25-003545 |
| 2025-01-0614:36 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-001911 |
| 2024-11-0722:50 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-122518 |
| 2024-11-0621:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-122229 |
| 2024-09-2720:05 ET | 8-K | 3.01 Delisting notice | 0000950170-24-109993 |
| 2024-08-1612:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-24-097816 |
| 2024-08-0822:06 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-093071 |
| 2024-08-0720:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-092780 |
| 2024-05-3020:05 ET | 8-K | 5.07 Shareholder vote results | 0000950170-24-066561 |
| 2024-05-0922:00 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-055981 |
| 2024-05-0820:10 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-055657 |
| 2024-05-0612:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-053215 |
| 2024-04-1120:05 ET | DEF 14A | Proxy statementPeriod 2024-05-29 | 0000950170-24-043692 |
| 2024-03-1320:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-030779 |
| 2024-02-2122:15 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-018093 |
| 2024-02-2121:10 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-017922 |
| 2024-01-0813:40 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-002731 |
| 2024-01-0221:41 ET | 8-K | 2.03 New direct financial obligation | 0000950170-24-000306 |
| 2023-12-1121:00 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0000950170-23-069380 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:08 ET. Listed shows no prices and gives no investment advice.